| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2021 | CDNA Caredx, Inc. | Dhingra Ankur70 | Chief Financial Officer | Buy | 5,000 | $42.34 | $211,693.50 | New | -17.0% | -70.9% | |
| Nov 24, 2021 | NEO Neogenomics Inc | Bonello William | President, Informatics | Sell | 25,000 | $37.13 | $928,250.00 | -61.8% | -50.3% | -72.7% | |
| Nov 24, 2021 | TWST Twist Bioscience Corp | Weiss Patrick86 | Chief Operating Officer | Sell | 2,801 | $95.29 | $266,907.29 | -5.6% | -45.6% | -73.4% | |
| Nov 23, 2021 | BDSX Biodesix Inc | Patience John | Director, 10% Owner, Chairman | Buy | 10,000 | $6.18 | $61,753.00 | +0.5% | -58.2% | -76.2% | |
| Nov 23, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 74,185 | $220.22 | $16,337,314.72 | -0.6% | -34.1% | +2.9% | |
| Nov 23, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 74,185 | $220.22 | $16,337,314.72 | -0.6% | -34.1% | +2.9% | |
| Nov 23, 2021 | GH Guardant Health, Inc. | Eltoukhy Helmy76 | Co-chief Executive Officer | Buy | 104,500 | $96.15 | $10,048,129.61 | +0.7% | -33.4% | -46.1% | |
| Nov 23, 2021 | GH Guardant Health, Inc. | Talasaz Amirali | Co-chief Executive Officer | Buy | 104,500 | $96.12 | $10,044,221.99 | +0.7% | -33.4% | -46.1% | |
| Nov 22, 2021 | BDSX Biodesix Inc | Schuler Jack W45 | Director, 10% Owner | Buy | 20,000 | $6.34 | $126,756.00 | +0.3% | -56.5% | -75.5% | |
| Nov 22, 2021 | TWST Twist Bioscience Corp | Banyai William81 | See Remarks | Sell | 19,983 | $101.83 | $2,034,838.42 | -0.8% | -46.9% | -74.3% | |
| Nov 19, 2021 | A Agilent Technologies, Inc. | McDonnell Padraig71 | Senior Vice President | Sell | 1,500 | $165.00 | $247,500.00 | -7.3% | -20.6% | -10.4% | |
| Nov 19, 2021 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 10,263 | $95.44 | $979,531.51 | -7.8% | -32.9% | -60.6% | |
| Nov 19, 2021 | BDSX Biodesix Inc | Schuler Jack W45 | Director, 10% Owner | Buy | 60,000 | $6.50 | $390,186.00 | +1.0% | -48.3% | -78.1% | |
| Nov 18, 2021 | DHR Danaher Corp /de/ | Hefner Linda P58 | Director | Sell | 4,548 | $308.85 | $1,404,627.06 | -8.7% | -14.3% | -16.3% | |
| Nov 18, 2021 | BDSX Biodesix Inc | Patience John | Director, 10% Owner, Chairman | Buy | 9,497 | $6.34 | $60,219.53 | +0.5% | -46.9% | -78.3% | |
| Nov 18, 2021 | BDSX Biodesix Inc | Schuler Jack W45 | Director, 10% Owner | Buy | 28,361 | $6.33 | $179,502.44 | +0.5% | -46.9% | -78.3% | |
| Nov 18, 2021 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 2,169 | $95.95 | $208,123.50 | -0.5% | -29.6% | -60.4% | |
| Nov 17, 2021 | BDSX Biodesix Inc | Schuler Jack W45 | Director, 10% Owner | Buy | 20,000 | $6.51 | $130,104.00 | +0.3% | -46.7% | -78.3% | |
| Nov 17, 2021 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 1,253 | $17.04 | $21,351.12 | -0.7% | -30.8% | -84.7% | |
| Nov 17, 2021 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec'y &Treasurer | Buy | 1,000 | $6.51 | $6,510.00 | +2.4% | -46.7% | -78.3% | |
| Nov 17, 2021 | TWST Twist Bioscience Corp | Johannessen Jan71 | Director | Sell | 5,000 | $115.17 | $575,850.00 | -72.5% | -48.5% | -78.1% | |
| Nov 17, 2021 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer | Sell | 1,253 | $17.04 | $21,351.12 | -1.5% | -30.8% | -84.7% | |
| Nov 17, 2021 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Buy | 3,000 | $6.46 | $19,374.90 | +44.4% | -46.7% | -78.3% | |
| Nov 17, 2021 | PSNL Personalis, Inc. | West John Stephen91 | President And CEO | Sell | 2,348 | $17.04 | $40,009.92 | -0.4% | -30.8% | -84.7% | |
| Nov 17, 2021 | ISPC Ispecimen Inc. | Curley Tracy | Chief Financial Officer | Buy | 10,000 | $5.21 | $52,080.00 | +125.0% | +6.9% | -66.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.